Join the Imvexxy group to help and get support from people like you.
Imvexxy News
Age at Start of Estrogen Therapy May Affect Alzheimer Disease Risk
WEDNESDAY, Sept. 24, 2025 – Estrogen therapy may reduce Alzheimer disease (AD) risk, with lower risk seen in association with early initiation, according to a study presented at the American...
Hormone Replacement Therapy Patches Safer Than Oral Delivery for Women With Diabetes
FRIDAY, Sept. 19, 2025 – Hormone replacement therapy (HRT) patches carry lower cardiovascular risk than oral HRT among women with type 2 diabetes, according to a study presented at the annual...
Type of Hormone Therapy Used After Menopause Affects Memory Performance
FRIDAY, Aug. 29, 2025 – Earlier age at menopause is associated with lower scores on all cognitive domains, and menopausal hormone therapy (MHT) differentially affects cognition, according to a study...
Use of Vaginal Estradiol Tablets Not Linked to Recurrent Stroke
THURSDAY, Aug. 21, 2025 – For women with a history of ischemic stroke, use of vaginal estradiol tablets is not associated with an increased rate of recurrent stroke, according to a study published...
Hormone Therapy Tied to Worse Bladder Health in Postmenopausal Women
TUESDAY, May 6, 2025 – Hormone therapy use is linked to worse bladder health in postmenopausal women, according to a study published online April 29 in Menopause. Camille P. Vaughan, M.D., from the ...
TherapeuticsMD Announces FDA Approval of Imvexxy (estradiol vaginal inserts) for the Treatment of Dyspareunia Due to Menopause
BOCA RATON, Fla., May 30, 2018 /PRNewswire/ – TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the United States Food and Drug Administration (FDA)...